EFFECTS OF TREATMENT AND CLINICAL EVENTS ON QUALITY OF LIFE IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A PRESPECIFIED ANALYSIS OF THE DAPA-CKD TRIAL

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/ba88ec7e89676c5057e807047a9bf8d6.pdf

Abstract Title

First Name *

Hiddo J. L.

Last Name *

Heerspink

Co-author 1

Niels Jongs n.jongs@umcg.nl University of Groningen Department of Clinical Pharmacy and Pharmacology Groningen

Co-author 2

Ricardo Correa-Rotter correarotter@gmail.com National Medical Science and Nutrition Institute Salvador Zubiran Department of Nephrology and Mineral Metabolism Mexico City

Co-author 3

Peter Rossing peter.rossing@regionh.dk University of Copenhagen Department of Clinical Medicine Copenhagen

Co-author 4

Robert D. Toto Robert.Toto@UTSouthwestern.edu UT Southwestern Medical Center Department of Internal Medicine Dallas

Co-author 5

David C. Wheeler d.wheeler@ucl.ac.uk University College London Department of Renal Medicine London

Co-author 6

John J. V. McMurray John.McMurray@glasgow.ac.uk University of Glasgow Institute of Cardiovascular and Medical Sciences, Glasgow

Co-author 7

Anna Maria Langkilde AnnaMaria.Langkilde@astrazeneca.com AstraZeneca BioPharmaceuticals R&D Gothenburg

Co-author 8

Priya Vart p.vart@umcg.nl University of Groningen Department of Clinical Pharmacy and Pharmacology Groningen

Co-author 9

Glenn M. Chertow gchertow@stanford.edu Stanford University Departments of Medicine and Epidemiology and Population Health Stanford

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15